MYCN and neuroblastoma: A striking example of this was demonstrated in studies of neuroblastoma cell lines, in which sensitivity to THZ1 was almost 10-fold greater in cells harboring amplified levels of the MYCN transcription factor compared to those without amplified MYCN [94].